Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CNS CoTSE:4076 -0.40%84 ROE % is 13.87% as of Feb. 2026, which is 0% below its 10-year median of 13.92. GuruFocus rates TSE:4076 with a GF Score™ of 84/100 and a GF Value™ of 円1,869.20 (Fairly Valued). The stock has 4 warning signs investors should review. Among 2,691 Software companies, CNS Co ranks better than 71.91% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. CNS Co's annualized net income for the quarter that ended in Feb. 2026 was 円567 Mil. CNS Co's average Total Stockholders Equity over the quarter that ended in Feb. 2026 was 円4,086 Mil. Therefore, CNS Co's annualized ROE % for the quarter that ended in Feb. 2026 was 13.87%.
The historical rank and industry rank for CNS Co's ROE % or its related term are showing as below:
TSE:4076'
s ROE % Range Over the Past 10 Years
Min: 9.89 Med: 13.92 Max: 20.56
Current: 14.51
During the past 8 years, CNS Co's highest ROE % was 20.56%. The lowest was 9.89%. And the median was 13.92%.
TSE:4076's ROE % is ranked better than 71.91% of 2691
companies
in the Software industry
Industry Median: 4.86
vs TSE:4076: 14.51
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Feb. 2026) net income data. The Revenue data used here is four times the quarterly (Feb. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
CNS Co ROE % Related Terms
CNS Co ROE % Historical Data
* Premium members only.
The historical data trend for CNS Co's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Information Technology Services subindustry, CNS Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CNS Co ROE % vs Software Industry
For the Software industry and Technology sector, CNS Co's ROE % distribution charts can be found below:
* The bar in red indicates where CNS Co's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Feb. 2026) net income data.
ROE % is displayed in the 30-year financial page.
CNS Co (TSE:4076) has a ROE % of 13.87% as of Feb. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on CNS Co and its competitors. This is near median its historical median of 13.92. Over the past decade, CNS Co's ROE % has ranged from 9.89 to 20.56. According to the industry distribution chart, CNS Co ranks #756 out of 2691 companies in the Software industry, placing it in the top 28.1%.
Is CNS Co's ROE % too high?
CNS Co's current ROE % of 13.87% is near median its 10-year median of 13.92. Over the past 10 years, this metric has ranged from a low of 9.89 to a high of 20.56. The Software industry median ROE % is 4.86. CNS Co's value of 13.87% is 185.4% above this industry median. Based on the distribution chart, CNS Co ranks #756 out of 2691 companies in the Software industry, which is above the industry midpoint. Overall, CNS Co has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CNS Co's ROE % compare to IBM and ACN?
According to the Software industry distribution chart, CNS Co ranks #756 out of 2691 companies for ROE %. This puts CNS Co in the upper half of its industry. The industry median ROE % is 4.86. CNS Co's value of 13.87% is 185.4% above this benchmark. Historically, CNS Co's own ROE % has ranged from 9.89 to 20.56 over the past decade. While the company's 10-year median is 13.92 vs. the industry median of 4.86, CNS Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Software company?
The median ROE % among Software companies is 4.86, based on 2,691 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CNS Co's current ROE % of 13.87% is 185.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on CNS Co and its competitors. For the Software industry, the median ROE % is 4.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CNS Co's current ROE % is 13.87%, which is near median its own 10-year median of 13.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CNS Co stock overvalued right now?
Based on GuruFocus' analysis, CNS Co (TSE:4076) is currently considered Fairly Valued. The stock's GF Value™ is 円1,869.20, compared to a current price of 円1,980.00 — trading 5.9% above its estimated fair value. The current ROE % is 13.87%, which is near median its 10-year median of 13.92 and 185.4% above the Software industry median of 4.86. CNS Co's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For CNS Co (TSE:4076), the current ROE % is 13.87% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CNS Co (TSE:4076) Overvalued in 2026?
Based on GuruFocus' analysis, CNS Co stock appears to be overvalued.
The current stock price of 円1,980.00 is trading 5.9% above its estimated GF Value™ of 円1,869.20.
GuruFocus considers CNS Co to be Fairly Valued.
Key valuation signals for TSE:4076:
ROE %: 13.87% (near median its 10-year median of 13.92)
GF Value™: 円1,869.20 vs. price of 円1,980.00 (5.9% above fair value)
Industry Position: 185.4% above the Software median (#756 of 2691)
No single metric tells the full story. See the TSE:4076 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CNS Co Ltd is an information technology solutions company engaged in providing system engineering services. The company offers various solutions to its clients such as consulting services related to digital transformation, data analysis solutions, business system integration, and the implementation, construction, and operation of optimal system infrastructure.
84GF Score
Get the complete analysis for TSE:4076
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4076 has been successfully added to your 
